Rachel Davies

Rachel Davies

Auto-generated profile, based on publicly available information

Rachel Davies

MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Genes & Development
Verified
Journal Article
Open access
PDF file
MLMikhail Lomonosov
Mikhail Lomonosov
SAShubha Anand
Shubha Anand
MSMahesh Sangrithi
Mahesh Sangrithi
RDRachel Davies
Rachel Davies
AVAshok R. Venkitaraman
Ashok R. Venkitaraman
How dividing mammalian cells overcome blocks to DNA replication by DNA damage, depleted nucleotide pools, or template-bound proteins is unclear. Here, we show that the response to blocked replication requires BRCA2, a suppressor of human breast cancer. By using two-dimensional gel electrophoresis, we demonstrate that Y-shaped DNA junctions at stalled replication forks disappear during genome-wide replication arrest in BRCA2-deficient cells, accompanied by double-strand DNA breakage. But activation of the replication checkpoint kinase Chk2 is unaffected, defining an unexpected function for BRCA2 in stabilizing DNA structures at stalled forks. We propose that in BRCA2 deficiency and related chromosomal instability diseases, the breakdown of replication forks, which arrest or pause during normal cell growth, triggers spontaneous DNA breakage, leading to mutability and cancer predisposition.

15 October 1998 in Genes & Development
Verified
Journal Article
Open access
PDF file
RDRachel C. Davies
Rachel C. Davies
Cinzia CalvioCinzia Calvio
Cinzia Calvio
EBEva Bratt
Eva Bratt
SLStefan H. Larsson
Stefan H. Larsson
ALAngus I. Lamond
Angus I. Lamond
NHNicholas D. Hastie
Nicholas D. Hastie
WT1 is essential for normal kidney development, and genetic alterations are associated with Wilms’ tumor, Denys Drash (DDS), and Frasier syndromes. Although generally considered a transcription factor this study has revealed that WT1 interacts with an essential splicing factor, U2AF65, and associates with the splicing machinery. WT1 is alternatively spliced and isoforms that include three amino acids, KTS, show stronger interaction with U2AF65 in vitro and better colocalization with splicing factors in vivo. Interestingly a mutation associated with DDS enhanced both −KTS WT1 binding to U2AF65 and splicing-factor colocalization. These data illustrate the functional importance of WT1 isoforms and suggest that WT1 plays a role in pre-mRNA splicing.

1 September 2000 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
NLNatalie A. Little
Natalie A. Little
NHNicholas D. Hastie
Nicholas D. Hastie
RDRachel C. Davies
Rachel C. Davies
The Wilms’ tumour suppressor gene WT1 is essential for the normal development of the genitourinary system. It appears to play a role in both transcriptional and post-transcriptional regulation of certain cellular genes. However, the mechanisms behind WT1 function are not clearly understood despite the identification of numerous potential target genes and the isolation of several WT1-binding proteins. This study therefore sets out to identify other WT1-associating proteins to help to unravel how WT1 interacts with the cellular machinery. We report the identification of a novel human WT1-associating protein, WTAP, which was isolated using the yeast two-hybrid system. Both in vitro and in vivo assays have shown that the interaction between WTAP and WT1 is specific and occurs endogenously in cells. The mouse homologue of WTAP was isolated and found to be >90% conserved at the nucleotide and protein levels. The human and mouse genes were mapped using fluorescence in situ hybridization to regions in chromosomes 6 (which is thought to harbour a tumour suppressor gene) and 17, respectively. The expression pattern of WTAP was investigated and shown to be ubiquitous, perhaps reflecting a housekeeping role. WTAP is a nuclear protein, which like WT1 localizes throughout the nucleoplasm as well as in speckles and partially co-localizes with splicing factors. Although the significance of this interaction is not yet known, WTAP promises to be an interesting WT1-binding partner.

1 April 1999
Verified
Journal Article
Closed access
RDR Davies
R Davies
AMA Moore
A Moore
ASAndreas Schedl
Andreas Schedl
EBE Bratt
E Bratt
KMK Miyahawa
K Miyahawa
NHN Hastie
N Hastie

1 August 1992 in Journal of General Virology
Verified
Journal Article
Closed access
RDR. C. Davies
R. C. Davies
KVK. H. Vousden
K. H. Vousden
Functional analysis of human papillomavirus type 16 E7 protein by complementation with adenovirus E1A mutants in baby rat kidney cells has shown that the retinoblastoma gene product (RB)-binding region of E7 can substitute in trans for that of E1A. An N-terminal E7 mutant was unable to complement an E1A mutant unable to bind p300, indicating that the two mutants were defective for functionally equivalent activities. E7 proteins with mutations within the RB-binding region were also unable to complement either the non-p300-binding E1A mutant or the N-terminal E7 mutant, suggesting that these mutations affect more than just RB binding.

1 April 1993
Verified
Journal Article
Closed access
JMJ D Morris
J D Morris
TCT Crook
T Crook
LBL R Bandara
L R Bandara
RDR Davies
R Davies
NLN B LaThangue
N B LaThangue
KVK H Vousden
K H Vousden